297-OR：老年糖尿病患者健康促进和糖尿病护理的交互式虚拟助手——一项随机对照试验

IF 7.5 1区医学 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes Pub Date : 2025-06-23 DOI:10.2337/db25-297-or

LUCAS S. MATZENBACHER, FREDERICO L. DA COSTA, LAURA G.B. DE BARROS, VICENZO GHENO, ISABELA S. MAIA, LUIZA M. BLANK, MARIA ANTÔNIA B. BRUM, LUCAS F. FONTOURA, JANINE ALESSI, GABRIELA H. TELO

{"title":"297-OR：老年糖尿病患者健康促进和糖尿病护理的交互式虚拟助手——一项随机对照试验","authors":"LUCAS S. MATZENBACHER, FREDERICO L. DA COSTA, LAURA G.B. DE BARROS, VICENZO GHENO, ISABELA S. MAIA, LUIZA M. BLANK, MARIA ANTÔNIA B. BRUM, LUCAS F. FONTOURA, JANINE ALESSI, GABRIELA H. TELO","doi":"10.2337/db25-297-or","DOIUrl":null,"url":null,"abstract":"Introduction and Objective: This study evaluated the impact of an interactive virtual assistant device, programmed with a behavioral intervention model, on mental-health and diabetes-related outcomes in older adults with type 2 diabetes (T2D) Methods: We conducted a randomized controlled trial enrolling participants aged 65 years or older with T2D. Participants were randomized to receive a Smart Speaker EchoDot 3rd Gen device, programmed with a behavioral intervention that included automatic medication reminders and health tips, or to continue with usual care for 12 weeks. The primary outcome was mental distress, assessed using the SRQ-20 scale. Secondary outcomes included quality of life (measured with the SF-36 scale), adherence to diabetes self-care behaviors (assessed with the SCI-R scale), and HbA1c. An analysis of covariance model was used to evaluate the impact of the intervention on study outcomes. Between-group mean differences after the intervention period, adjusted for baseline data and relevant covariates, were reported, with statistical significance set at an alpha level of 0.05 Results: A total of 112 participants (63% female, 63% white; mean age: 72.5 years; mean T2D duration: 16.9 years; mean HbA1c: 7.9%) were randomized, with 103 completing the trial. At 12 weeks, participants in the intervention group showed a reduction in mental distress (mean difference: -1.46; 95% CI -2.73 to -0.19; p=0.024), an increase in quality of life (mean difference: 9.46; 95% CI 3.65 to 15.26; p=0.001), greater adherence to diabetes self-care behaviors (mean difference: 3.40; 95% CI 1.61 to 5.19; p&lt;0.001), and lower HbA1c (mean difference: -0.48; 95% CI -0.85 to -0.11; p=0.011) when compared to those in the usual care group Conclusion: In this randomized controlled trial, a smart-speaker-based intervention was associated with significant improvements in mental health, quality of life, diabetes self-care behaviors, and HbA1c in older adults with T2D Disclosure L.S. Matzenbacher: None. F.L. da Costa: None. L.G.B. de Barros: None. V. Gheno: None. I.S. Maia: None. L.M. Blank: None. M.B. Brum: None. L.F. Fontoura: None. J. Alessi: None. G.H. Telo: None. Funding Brazilian National Council for Scientific and Technological Development (CNPq/MCTI/FNDCT 18/2021 grant)","PeriodicalId":11376,"journal":{"name":"Diabetes","volume":"19 1","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"297-OR: Interactive Virtual Assistant for Health Promotion and Diabetes Care in Older Adults with Diabetes—A Randomized Controlled Trial\",\"authors\":\"LUCAS S. MATZENBACHER, FREDERICO L. DA COSTA, LAURA G.B. DE BARROS, VICENZO GHENO, ISABELA S. MAIA, LUIZA M. BLANK, MARIA ANTÔNIA B. BRUM, LUCAS F. FONTOURA, JANINE ALESSI, GABRIELA H. TELO\",\"doi\":\"10.2337/db25-297-or\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction and Objective: This study evaluated the impact of an interactive virtual assistant device, programmed with a behavioral intervention model, on mental-health and diabetes-related outcomes in older adults with type 2 diabetes (T2D) Methods: We conducted a randomized controlled trial enrolling participants aged 65 years or older with T2D. Participants were randomized to receive a Smart Speaker EchoDot 3rd Gen device, programmed with a behavioral intervention that included automatic medication reminders and health tips, or to continue with usual care for 12 weeks. The primary outcome was mental distress, assessed using the SRQ-20 scale. Secondary outcomes included quality of life (measured with the SF-36 scale), adherence to diabetes self-care behaviors (assessed with the SCI-R scale), and HbA1c. An analysis of covariance model was used to evaluate the impact of the intervention on study outcomes. Between-group mean differences after the intervention period, adjusted for baseline data and relevant covariates, were reported, with statistical significance set at an alpha level of 0.05 Results: A total of 112 participants (63% female, 63% white; mean age: 72.5 years; mean T2D duration: 16.9 years; mean HbA1c: 7.9%) were randomized, with 103 completing the trial. At 12 weeks, participants in the intervention group showed a reduction in mental distress (mean difference: -1.46; 95% CI -2.73 to -0.19; p=0.024), an increase in quality of life (mean difference: 9.46; 95% CI 3.65 to 15.26; p=0.001), greater adherence to diabetes self-care behaviors (mean difference: 3.40; 95% CI 1.61 to 5.19; p&lt;0.001), and lower HbA1c (mean difference: -0.48; 95% CI -0.85 to -0.11; p=0.011) when compared to those in the usual care group Conclusion: In this randomized controlled trial, a smart-speaker-based intervention was associated with significant improvements in mental health, quality of life, diabetes self-care behaviors, and HbA1c in older adults with T2D Disclosure L.S. Matzenbacher: None. F.L. da Costa: None. L.G.B. de Barros: None. V. Gheno: None. I.S. Maia: None. L.M. Blank: None. M.B. Brum: None. L.F. Fontoura: None. J. Alessi: None. G.H. Telo: None. Funding Brazilian National Council for Scientific and Technological Development (CNPq/MCTI/FNDCT 18/2021 grant)\",\"PeriodicalId\":11376,\"journal\":{\"name\":\"Diabetes\",\"volume\":\"19 1\",\"pages\":\"\"},\"PeriodicalIF\":7.5000,\"publicationDate\":\"2025-06-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2337/db25-297-or\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2337/db25-297-or","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

摘要

简介和目的：本研究评估了一种带有行为干预模型的交互式虚拟辅助设备对老年2型糖尿病（T2D）患者心理健康和糖尿病相关结局的影响。方法：我们进行了一项随机对照试验，招募了65岁及以上的T2D患者。参与者随机接受智能扬声器EchoDot第三代设备，该设备带有行为干预程序，包括自动药物提醒和健康提示，或者继续接受12周的常规护理。主要结果为精神痛苦，采用SRQ-20量表进行评估。次要结果包括生活质量（用SF-36量表测量）、糖尿病自我护理行为的依从性（用SCI-R量表评估）和HbA1c。采用协方差分析模型评价干预对研究结果的影响。经基线资料及相关协变量调整后，报告干预期后组间平均差异，alpha水平为0.05，差异有统计学意义。结果：共有112名参与者(63%女性，63%白人；平均年龄：72.5岁；T2D平均病程：16.9年；平均HbA1c: 7.9%)被随机分组，103人完成了试验。在12周时，干预组的参与者表现出精神痛苦的减少(平均差异：-1.46；95% CI -2.73 ~ -0.19；P =0.024)，生活质量提高(平均差值：9.46；95% CI 3.65 ~ 15.26；P =0.001)，更坚持糖尿病自我护理行为(平均差异：3.40；95% CI 1.61 ~ 5.19；p<0.001)和较低的HbA1c(平均差异：-0.48；95% CI -0.85 ~ -0.11；p=0.011)结论：在这项随机对照试验中，基于智能扬声器的干预与老年T2D患者的心理健康、生活质量、糖尿病自我护理行为和HbA1c的显著改善相关。达·科斯塔：没有。L.G.B. de Barros：没有。V. Gheno：没有。I.S.玛雅：没有。L.M.布兰克：没有。M.B.布鲁姆：没有。l·f·丰图拉：没有。J.阿莱西：没有。G.H.泰罗：没有。资助巴西国家科学和技术发展委员会（CNPq/MCTI/FNDCT 18/2021赠款）

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

297-OR: Interactive Virtual Assistant for Health Promotion and Diabetes Care in Older Adults with Diabetes—A Randomized Controlled Trial

Introduction and Objective: This study evaluated the impact of an interactive virtual assistant device, programmed with a behavioral intervention model, on mental-health and diabetes-related outcomes in older adults with type 2 diabetes (T2D) Methods: We conducted a randomized controlled trial enrolling participants aged 65 years or older with T2D. Participants were randomized to receive a Smart Speaker EchoDot 3rd Gen device, programmed with a behavioral intervention that included automatic medication reminders and health tips, or to continue with usual care for 12 weeks. The primary outcome was mental distress, assessed using the SRQ-20 scale. Secondary outcomes included quality of life (measured with the SF-36 scale), adherence to diabetes self-care behaviors (assessed with the SCI-R scale), and HbA1c. An analysis of covariance model was used to evaluate the impact of the intervention on study outcomes. Between-group mean differences after the intervention period, adjusted for baseline data and relevant covariates, were reported, with statistical significance set at an alpha level of 0.05 Results: A total of 112 participants (63% female, 63% white; mean age: 72.5 years; mean T2D duration: 16.9 years; mean HbA1c: 7.9%) were randomized, with 103 completing the trial. At 12 weeks, participants in the intervention group showed a reduction in mental distress (mean difference: -1.46; 95% CI -2.73 to -0.19; p=0.024), an increase in quality of life (mean difference: 9.46; 95% CI 3.65 to 15.26; p=0.001), greater adherence to diabetes self-care behaviors (mean difference: 3.40; 95% CI 1.61 to 5.19; p<0.001), and lower HbA1c (mean difference: -0.48; 95% CI -0.85 to -0.11; p=0.011) when compared to those in the usual care group Conclusion: In this randomized controlled trial, a smart-speaker-based intervention was associated with significant improvements in mental health, quality of life, diabetes self-care behaviors, and HbA1c in older adults with T2D Disclosure L.S. Matzenbacher: None. F.L. da Costa: None. L.G.B. de Barros: None. V. Gheno: None. I.S. Maia: None. L.M. Blank: None. M.B. Brum: None. L.F. Fontoura: None. J. Alessi: None. G.H. Telo: None. Funding Brazilian National Council for Scientific and Technological Development (CNPq/MCTI/FNDCT 18/2021 grant)

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Diabetes 医学-内分泌学与代谢

CiteScore

12.50

自引率

2.60%

发文量

1968

审稿时长

1 months

期刊介绍： Diabetes is a scientific journal that publishes original research exploring the physiological and pathophysiological aspects of diabetes mellitus. We encourage submissions of manuscripts pertaining to laboratory, animal, or human research, covering a wide range of topics. Our primary focus is on investigative reports investigating various aspects such as the development and progression of diabetes, along with its associated complications. We also welcome studies delving into normal and pathological pancreatic islet function and intermediary metabolism, as well as exploring the mechanisms of drug and hormone action from a pharmacological perspective. Additionally, we encourage submissions that delve into the biochemical and molecular aspects of both normal and abnormal biological processes. However, it is important to note that we do not publish studies relating to diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus. Our aim is to provide a platform for research that contributes to advancing our understanding of the underlying mechanisms and processes of diabetes.